Irvine, CA, USA – When the U.S. Food and Drug Administration gave controversial accelerated approval to the first Alzheimer’s drug in nearly 20 years, it had a...
Amsterdam, NL – Last year, the FDA gave accelerated approval of the antibody aducanumab (marketed as Aduhelm by Biogen) for the treatment of Alzheimer’s disease...
Investigators found that a surprisingly large proportion of some infants with four copies of the SMN2 gene, whose families decided to postpone treatment, showed...
Madrid, Spain– Stigma, depressive symptoms and feelings of hopelessness are common problems in the early stages of Alzheimer's disease (AD). A recent study...
IOS Press would like to recognize Sudhir Srivastava's outstanding achievement as the 2022 recipient of the Don Listwin Award for Outstanding Contribution to...
Doha, Qatar – New research from Qatar University College of Health Sciences (QU-CHS) and the School of Nursing at the University of Pennsylvania has found that...
Amsterdam, NL – The Journal of Parkinson’s Disease (JPD), published by IOS Press, is pleased to announce that beginning in January 2023, JPD will transition to...
Michigan, USA –Long-term “study of studies” in Latino and non-Latino older adults shows clear hypertension link, but mystery still remains about why dementia...
Cleveland, OH, USA – Older people who were infected with COVID-19 show a substantially higher risk – as much as 50% to 80% higher than a control group – of...
Amsterdam, NL – IOS Press is firmly committed to supporting the implementation of FAIR’s guiding principles to make data findable, accessible, interoperable...
Rome, Italy – The elderly population has been hit with some of the worst effects of the COVID-19 pandemic, with a considerable mortality burden in particular...
